Masimo | MASI - Vertriebs- Und Verwaltungskosten

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




Vertriebs- Und Verwaltungskosten Veränderung Datum
Abbott USD 3.27B 138M 2026-03
Accuray USD 127.32M 500.16M 2025-09
Align Technology USD 441.68M 23.88M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
General Electric Aerospace USD 1.08B 496M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12